A partnership led by the Medical Research Council (MRC) has awarded the University of Cambridge £25 million to provide cutting-edge equipment and infrastructure for its clinical research, from imaging single disease cells through to improved targeting of treatments for patients.
An experimental drug currently being trialled for influenza and Ebola viruses could have a new target: norovirus, often known as the winter vomiting virus. A team of researchers at the University of Cambridge has shown that the drug, favipiravir, is effective at reducing – and in some cases eliminating – norovirus infection in mice.
At a seminar tomorrow (22 October 2014) archaeologist Craig Cessford will talk about the challenges of working on ‘clearance deposits’. He will use, as one of his examples, the recent excavation of a site in historic Cambridge that yielded a cache of teapots, and other items, that had lain undisturbed for more than 200 years.
The largest ever Cambridge Festival of Ideas launches on Monday with 250 events celebrating the very best of arts, politics and culture.
Scientists in Cambridge have found hidden signatures in the brains of people in a vegetative state, which point to networks that could support consciousness even when a patient appears to be unconscious and unresponsive. The study could help doctors identify patients who are aware despite being unable to communicate.
New research shows that chimpanzees search for the right tools from a key plant species when preparing to ‘ant dip’ - a crafty technique enabling them to feast on army ants without getting bitten. The study shows that army ants are not a poor substitute for preferred foods, but a staple part of chimpanzee diets.
AstraZeneca, its global biologics research and development arm, MedImmune, and the University of Cambridge today announce four new collaborations, building on their existing partnership. The latest collaborations reinforce AstraZeneca’s commitment to research in Cambridge following the company’s decision to locate one of its three global R&D centres and its global headquarters in the city that has been home to MedImmune’s biologics research laboratories for 25 years.